Ophthalmic Plastic and Reconstructive Surgery · Knoxville, TN
NPI
1891061396
Since 2012
Specialty
Ophthalmic Plastic and Reconstructive Surgery
Code 207WX0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4528 Chapman Hwy
Knoxville, TN, 37920
Phone (865) 579-3920
Groups this clinician bills Medicare through
Medicare paid, 2024
$310K
8,817 services
Medicare patients, 2024
887
Average age 75
Drug cost, 2024
$331K
1,201 prescriptions
Company payments, 2025
$808
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew J Anzeljc was code J0588 (injection, incobotulinumtoxin a, 1 unit), 3,758 times for 21 patients. In total Andrew J Anzeljc billed 8,817 services in 69 codes, and Medicare paid $310K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 3,758 | 21 | $3.95 | $15K |
| 92012 Ophthalmological E&M | Office | 317 | 245 | $56.07 | $18K |
| 92285 Standard X-ray | Office | 282 | 279 | $14.41 | $4,063 |
| 99214 Office E&M - Established | Office | 268 | 250 | $76.52 | $21K |
| 99204 Office E&M - New | Office | 239 | 239 | $106.76 | $26K |
| 67904 Eye | Facility | 86 | 86 | $565.58 | $49K |
| 92002 Ophthalmological E&M | Office | 84 | 84 | $56.86 | $4,776 |
| 15823 Skin | Facility | 72 | 72 | $544.04 | $39K |
| 64612 Musculoskeletal | Office | 67 | 26 | $102.46 | $6,865 |
| 67825 Eye | Office | 28 | 21 | $93.90 | $2,629 |
| 67917 Eye | Facility | 27 | 26 | $305.82 | $8,257 |
| 67840 Eye | Office | 25 | 25 | $176.93 | $4,423 |
| 11440 Skin Lesion Excision | Office | 23 | 23 | $88.81 | $2,043 |
| 92082 Vision, Hearing, and Speech Services | Office | 22 | 22 | $29.43 | $648 |
| 15823 Skin | Office | 20 | 20 | $561.65 | $11K |
By year: 2022 $280K for 5,904 services; 2023 $316K for 5,697 services; 2024 $310K for 8,817 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew J Anzeljc prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 822 prescriptions and refills. In total Andrew J Anzeljc wrote 1,201 Medicare prescriptions that cost $331K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 822 | 839 | 696 | $9,937 |
| Erythromycin Erythromycin Base | 169 | 169 | 159 | $1,849 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 55 | 55 | 54 | $135 |
| Doxycycline Hyclate Generic | 46 | 46 | 40 | $473 |
| Prednisolone Acetate Generic | 27 | 29 | 23 | $714 |
Brand drugs: 382 claims; generic drugs: 819 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew J Anzeljc $808 ($808 in general payments such as food, travel and fees) from 9 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $271.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 9 | $271 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $125 |
| Alcon Vision LLC ALC | 1 | $122 |
| Astellas Pharma Global Development 4503.T | 1 | $92.09 |
| Mallinckrodt Hospital Products Inc. | 3 | $76.04 |
| Stryker Corporation SYK | 1 | $53.18 |
| Abbvie Inc. ABBV | 1 | $31.65 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $19.05 |
| Amgen Inc. AMGN | 1 | $18.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.